Overview:

Summary

Medical equipment offering, “Belgium Diabetes Care Devices Market Outlook to 2016” provides key market data on the Belgium diabetes care devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories - Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

• Market size and company share data for two diabetes care devices market categories - Glucose Monitoring and Insulin Delivery.

• Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within two market categories.

• Data from 2002 to 2009, forecast forward for 7 years to 2016.

• 2009 company shares and distribution shares data for each of the two market categories.

• Global corporate-level profiles of key companies operating within the Belgium diabetes care devices market. Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Bayer HealthCare AG, Abbott Laboratories, Medtronic, Inc., Becton, Dickinson and Company and Novo Nordisk A/S.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.

• Develop market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the Belgium diabetes care devices competitive landscape.

• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd.
Sanofi-Aventis
LifeScan, Inc.
Bayer HealthCare AG
Eli Lilly and Company
Medtronic, Inc.
Novo Nordisk A/S
B. Braun Melsungen AG
Abbott Laboratories
Becton, Dickinson and Company
Smiths Medical
Terumo Corporation
ARKRAY, Inc.
Apex Biotechnology Corp.
Animas Corporation

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What is This Report About?

3 Diabetes Care Devices In Belgium

3.1 Diabetes Care Devices, Market Segmentation

3.2 Diabetes Care Devices, Belgium, Overall Revenue ($m), 2002-2016

3.3 Diabetes Care Devices Market, Belgium, Revenue Mix ($m), 2009

3.4 Diabetes Care Devices Market, Belgium, Category Contribution (%), 2009

3.5 Diabetes Care Devices, Belgium, Category Volume (Units), 2002-2016

3.6 Diabetes Care Devices, Belgium, Company Share (2008-2009)

4 Glucose Monitoring In Belgium

4.1 Glucose Monitoring, Market Segmentation

4.2 Glucose Monitoring Market, Belgium, Revenue Mix ($m), 2009

4.3 Glucose Monitoring Market, Belgium, Category Contribution (%), 2009

4.4 Glucose Monitoring Overall Revenue (2002-2016)

4.4.1 Blood Glucose Meters Revenue (2002-2016)

4.5 Glucose Monitoring Overall Volume (2002-2016)

4.5.1 Blood Glucose Meters Revenue (2002-2016)

4.6 Glucose Monitoring Average Price (2002-2016)

4.7 Glucose Monitoring Distribution Share (2008-2009)

4.8 Glucose Monitoring, Belgium, Company Share (2008-2009)

5 Insulin Delivery In Belgium

5.1 Insulin Delivery, Market Segmentation

5.2 Insulin Delivery Market, Belgium, Revenue Mix ($m), 2009

5.3 Insulin Delivery Market, Belgium, Category Contribution (%), 2009

5.4 Insulin Delivery Overall Revenue (2002-2016)

5.4.1 Insulin Pens Revenue (2002-2016)

5.5 Insulin Delivery Overall Volume (2002-2016)

5.5.1 Insulin Pens Volume (2002-2016)

5.6 Insulin Delivery Average Price (2002-2016)

5.7 Insulin Delivery Distribution Share (2008-2009)

5.8 Insulin Delivery, Belgium, Company Share (2008-2009)

6 Overview of Key Companies in Belgium Diabetes Care Devices Market

6.1 F. Hoffmann-La Roche Ltd.

6.1.1 Company Overview

6.1.2 Share in the Belgium Diabetes Care Devices Market

6.2 Sanofi-Aventis

6.2.1 Company Overview

6.2.2 Share in the Belgium Diabetes Care Devices Market

6.3 LifeScan, Inc.

6.3.1 Company Overview

6.3.2 Share in the Belgium Diabetes Care Devices Market

6.4 Bayer HealthCare AG

6.4.1 Company Overview

6.4.2 Share in the Belgium Diabetes Care Devices Market

6.5 Eli Lilly and Company

6.5.1 Company Overview

6.5.2 Share in the Belgium Diabetes Care Devices Market

6.6 Medtronic, Inc.

6.6.1 Company Overview

6.6.2 Share in the Belgium Diabetes Care Devices Market

6.7 Novo Nordisk A/S

6.7.1 Company Overview

6.7.2 Share in the Belgium Diabetes Care Devices Market

6.8 B. Braun Melsungen AG

6.8.1 Company Overview

6.9 Abbott Laboratories

6.9.1 Company Overview

6.10 Becton, Dickinson and Company

6.10.1 Company Overview

6.11 Smiths Medical

6.11.1 Company Overview

6.12 Terumo Corporation

6.12.1 Company Overview

6.13 ARKRAY, Inc.

6.13.1 Company Overview

6.14 Apex Biotechnology Corp.

6.14.1 Company Overview

6.15 Animas Corporation

6.15.1 Company Overview

 

7 Diabetes Care Devices Market Pipeline Products

8 Appendix

8.1 Definitions of Markets Covered in the Report

8.1.1 Diabetes Care Devices

8.2 Research Methodology

8.3 Secondary Research

8.4 Primary Research

8.5 Models

8.6 Forecasts

8.7 Expert Panels

8.8 GlobalData Consulting

8.9 Currency Conversion

8.10 Contact Us

8.11 Disclaimer

1.1 List of Tables

Table 1:Diabetes Care Devices, Belgium, Overall Revenue ($m), 2002-2016

Table 2: Diabetes Care Devices Market, Belgium, Category Contribution (%), 2009

Table 3:Diabetes Care Devices, Belgium, Cross-Segment Analysis, 2002-2016

Table 4:Diabetes Care Devices, Belgium, Overall Revenue ($m), Historic, 2002-2009

Table 5:Diabetes Care Devices, Belgium, Overall Revenue ($m), Forecast, 2009-2016

Table 6:Diabetes Care Devices, Belgium, Category Volume (Units), 2002-2016

Table 7:Diabetes Care Devices, Belgium, Category Volume (Units), Historic, 2002-2009

Table 8:Diabetes Care Devices, Belgium, Category Volume (Units), Forecast, 2009-2016

Table 9:Diabetes Care Devices, Belgium, Company Share by Revenue ($m), 2008-2009

Table 10: Glucose Monitoring Market, Belgium, Category Contribution (%), 2009

Table 11:Glucose Monitoring, Belgium, Revenue ($m) by Segment, Historic, 2002-2009

Table 12:Glucose Monitoring, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016

Table 13:Blood Glucose Meters, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009

Table 14:Blood Glucose Meters, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016

Table 15:Glucose Monitoring, Belgium, Volume (Units) by Segment, Historic, 2002-2009

Table 16:Glucose Monitoring, Belgium, Volume (Units) by Segment, Forecast, 2009-2016

Table 17:Blood Glucose Meters, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009

Table 18:Blood Glucose Meters, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016

Table 19:Glucose Monitoring, Belgium, Average Price ($), Historic, 2002-2009

Table 20:Glucose Monitoring, Belgium, Average Price ($), Forecast, 2009-2016

Table 21:Glucose Monitoring, Belgium, Distribution Share by Revenue ($m), 2008-2009

Table 22:Glucose Monitoring, Belgium, Company Share by Revenue ($m), 2008-2009

Table 23: Insulin Delivery Market, Belgium, Category Contribution (%), 2009

Table 24:Insulin Delivery, Belgium, Revenue ($m) by Segment, Historic, 2002-2009

Table 25:Insulin Delivery, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016

Table 26:Insulin Pens, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009

Table 27:Insulin Pens, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016

Table 28:Insulin Delivery, Belgium, Volume (Units) by Segment, Historic, 2002-2009

Table 29:Insulin Delivery, Belgium, Volume (Units) by Segment, Forecast, 2009-2016

Table 30:Insulin Pens, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009

Table 31:Insulin Pens, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016

Table 32:Insulin Delivery, Belgium, Average Price ($), Historic, 2002-2009

Table 33:Insulin Delivery, Belgium, Average Price ($), Forecast, 2009-2016

Table 34:Insulin Delivery, Belgium, Distribution Share by Revenue ($m), 2008-2009

Table 35:Insulin Delivery, Belgium, Company Share by Revenue ($m), 2008-2009

Table 36: Diabetes Care Devices Pipeline Products

Table 37: USD to Local Currency, Belgium, Average Actual Rate 2002-2009

1.2 List of Figures

Figure 1: Diabetes Care Devices, Market Segmentation

Figure 2: Diabetes Care Devices, Belgium, Overall Revenue ($m), 2002-2016

Figure 3: Diabetes Care Devices Market, Belgium, Revenue Mix ($m), 2009

Figure 4: Diabetes Care Devices Market, Belgium, Category Contribution (%), 2009

Figure 5: Diabetes Care Devices, Belgium, Cross-Segment Analysis, 2002-2016

Figure 6: Diabetes Care Devices, Belgium, Overall Revenue ($m), Historic, 2002-2009

Figure 7: Diabetes Care Devices, Belgium, Overall Revenue ($m), Forecast, 2009-2016

Figure 8: Diabetes Care Devices, Belgium, Category Volume (Units), 2002-2016

Figure 9: Diabetes Care Devices, Belgium, Category Volume (Units), Historic, 2002-2009

Figure 10: Diabetes Care Devices, Belgium, Category Volume (Units), Forecast, 2009-2016

Figure 11: Diabetes Care Devices, Belgium, Company Share (%), 2009

Figure 12: Glucose Monitoring, Market Segmentation

Figure 13: Glucose Monitoring Market, Belgium, Revenue Mix ($m), 2009

Figure 14: Glucose Monitoring Market, Belgium, Category Contribution (%), 2009

Figure 15: Glucose Monitoring, Belgium, Revenue ($m) by Segment, Historic, 2002-2009

Figure 16: Glucose Monitoring, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016

Figure 17: Blood Glucose Meters, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009

Figure 18: Blood Glucose Meters, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016

Figure 19: Glucose Monitoring, Belgium, Volume (Units) by Segment, Historic, 2002-2009

Figure 20: Glucose Monitoring, Belgium, Volume (Units) by Segment, Forecast, 2009-2016

Figure 21: Blood Glucose Meters, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009

Figure 22: Blood Glucose Meters, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016

Figure 23: Glucose Monitoring, Belgium, Company Share (%), 2009

Figure 24: Insulin Delivery, Market Segmentation

Figure 25: Insulin Delivery Market, Belgium, Revenue Mix ($m), 2009

Figure 26: Insulin Delivery Market, Belgium, Category Contribution (%), 2009

Figure 27: Insulin Delivery, Belgium, Revenue ($m) by Segment, Historic, 2002-2009

Figure 28: Insulin Delivery, Belgium, Revenue ($m) by Segment, Forecast, 2009-2016

Figure 29: Insulin Pens, Belgium, Revenue ($m) by Sub-Segment, Historic, 2002-2009

Figure 30: Insulin Pens, Belgium, Revenue ($m) by Sub-Segment, Forecast, 2009-2016

Figure 31: Insulin Delivery, Belgium, Volume (Units) by Segment, Historic, 2002-2009

Figure 32: Insulin Delivery, Belgium, Volume (Units) by Segment, Forecast, 2009-2016

Figure 33: Insulin Pens, Belgium, Volume (Units) by Sub-Segment, Historic, 2002-2009

Figure 34: Insulin Pens, Belgium, Volume (Units) by Sub-Segment, Forecast, 2009-2016

Figure 35: Insulin Delivery, Belgium, Company Share (%), 2009

Figure 36: F. Hoffmann-La Roche Ltd, Company Share (%), Belgium Diabetes Care Devices Market, 2009

Figure 37: Sanofi-Aventis, Company Share (%), Belgium Diabetes Care Devices Market, 2009

Figure 38: LifeScan, Inc., Company Share (%), Belgium Diabetes Care Devices Market, 2009

Figure 39: Bayer HealthCare AG, Company Share (%), Belgium Diabetes Care Devices Market, 2009

Figure 40: Eli Lilly and Company, Company Share (%), Belgium Diabetes Care Devices Market, 2009

Figure 41: Medtronic, Inc., Company Share (%), Belgium Diabetes Care Devices Market, 2009

Figure 42: Novo Nordisk A/S, Company Share (%), Belgium Diabetes Care Devices Market, 2009

Figure 43: GlobalData Methodology